Posts filed under ‘GUIDELINES’

Updated Recommendations for the Use of Typhoid Vaccine — Advisory Committee on Immunization Practices, United States, 2015

MMWR Weekly March 27, 2015 V.64  N.11 P.305-308

Brendan R. Jackson, MD, Shahed Iqbal, PhD, Barbara Mahon, MD.

1Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 2Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC (Corresponding author: Brendan R. Jackson, iyn0@cdc.gov, 404-639-0536)

These revised recommendations of the Advisory Committee on Immunization Practices update recommendations published in MMWR in 1994 (1) and include updated information on the two currently available vaccines and on vaccine safety.

They also include an update on the epidemiology of enteric fever in the United States, focusing on increasing drug resistance in Salmonella enterica serotype Typhi, the cause of typhoid fever, as well as the emergence of Salmonella serotype Paratyphi A, a cause of paratyphoid fever, against which typhoid vaccines offer little or no protection…..

FULL TEXT

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a4.htm?s_cid=mm6411a4_e

PDF See P.305-308

http://www.cdc.gov/mmwr/pdf/wk/mm6411.pdf

 

March 29, 2015 at 10:36 am

Antimicrobial prophylaxis for surgery: An advisory statement from the national surgical infection prevention project 

Clinical Infectious Diseases June15, 2004 V.38 N.12 P.1706-1715

REVIEW

Bratzler, D.W. ,  Houck, P.M. 

OK Foundation for Medical Quality, 14000 Quail Springs Pkwy., Oklahoma City, OK 73134-2627, United States

In January 2003, leadership of the Medicare National Surgical Infection Prevention Project hosted the Surgical Infection Prevention Guideline Writers Workgroup (SIPGWW) meeting.

The objectives were to review areas of agreement among the most-recently published guidelines for surgical antimicrobial prophylaxis, to address inconsistencies, and to discuss issues not currently addressed.

The participants included authors from most of the groups that have published North American guidelines for antimicrobial prophylaxis, as well as authors from several specialty colleges. Nominal group process was used to draft a consensus paper that was widely circulated for comment.

The consensus positions of SIPGWW include that infusion of the first antimicrobial dose should begin within 60 min before surgical incision and that prophylactic antimicrobials should be discontinued within 24 h after the end of surgery.

This advisory statement provides an overview of other issues related to antimicrobial prophylaxis, including specific suggestions regarding antimicrobial selection.

PDF

http://cid.oxfordjournals.org/content/38/12/1706.full.pdf+html

March 9, 2015 at 9:16 am

CONSENSO GeSIDA TARV en adultos

2015-01 CONSENSO GeSIDA TARV en adultos EIMC 101 págs.

PDF

http://www.seimc.org/contenidos/gruposdeestudio/gesida/dcientificos/documentos/2015/gesida-guiasclinicas-2015-tar.pdf

 

March 6, 2015 at 8:56 am

2013-08 INTERNATIONAL CONSENSUS on PJI – PHILADELPHIA

Proceedings of the International Consensus Meeting on PJI
Delegates will serve in one of the following Workgroups:
Mitigation and Education on Comorbidities (Medical Optimization)
Patient Preparation (Skin Preparation/Hand-washing)
Perioperative Antibiotics
Operative Environment
Blood Conservation
Prosthesis Selection
Diagnosis: Laboratory, Imaging, Pathology
Wound Management
Spacer
Irrigation and Debridement
Antibiotic treatment and Timing of Reimplantation
One-stage vs Two- stage Exchange
Management of Fungal or Atypical PJI
Antimicrobial Therapy
Prevention of Late PJI (dental prophylaxis, Abx prophylaxis, monitoring)

FULL TEXT
http://www.msis-na.org/international-consensus/

PDF
http://www.msis-na.org/wp-content/themes/msis-temp/pdf/ism-periprosthetic-joint-information.pdf

March 1, 2015 at 1:59 pm

Update on pathogenesis and diagnosis of intravascular catheter-related infections.

Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 4:16-21.

Pascual A1, Cercenado E, Salavert M, Elías García-Sánchez J, Eiros JM, Liñares J, Fernández C, Vila J.

1Departamento de Microbiología, Hospital Universitario Virgen Macarena, Facultad de Medicina, Sevilla, Spain. apascual@us.es

Abstract

Infections associated with the use of intravascular catheters cause a substantial morbidity and mortality.

New knowledge in the pathogenesis of catheter related bloodstream infections has led to advances in the prevention and management of these infections.

The purpose of the present chapter is to review the most relevant data published recently on pathogenesis and diagnosis of intravascular catheter-related infections.

It is focus in four different aspects:

a) pathogenesis of catheter-related infections and particularly factors affecting biofilm formation and modulation;

b) pathogenesis of intravascular catheter-related infections caused by Staphylococcus lugdunensis; c) news on microbiological diagnosis of catheter-related bacteremia; and

d) evaluation of current use of blood cultures in the era of continuous monitoring blood cultures systems.

PDF english

http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90002228&pident_usuario=0&pcontactid=&pident_revista=28&ty=140&accion=L&origen=zonadelectura&web=www.elsevier.es&lan=en&fichero=28v29nSupl.4a90002228pdf001.pdf

 

February 26, 2015 at 12:33 pm

GUIA de Atención de TBC Pulmonar y Extrapulmonar – Colombia

INDICE

  1. Introducción…………………………………………………………………………27
  2. Metodología………………………………………………………………………….27
  3. Justificación …………………………………………………………………………28
  4. Epidemiología……………………………………………………………………….29
  5. Objetivos …………………………………………………………………………….31

5.1 Objetivos generales……………………………………………………………… ..31

5.2 Objetivos específicos …………………………………………………………….. 31

  1. Población objeto…………………………………………………………………. 32
  2. Definición ………………………………………………………………………….. 32
  3. Etiopatogenia…………………………………………………………………….. 32
  4. Historia natural de la tuberculosis…………………………………… …37
  5. Diagnóstico de la enfermedad tuberculosa………………………. …39

10.1 Tuberculosis pulmonar…………………………………………………….. …41

10.2 Tuberculosis extrapulmonar…………………………………………… ….45

10.3 Tuberculosis pleural ………………………………………………………….. 46

10.4 Tuberculosis ganglionar …………………………………………………….. 47

10.5 Tuberculosis genitourinaria ………………………………………………. 48

10.6 Tuberculosis osteoarticular ……………………………………………… ..48

10.7 Tuberculosis del sistema nervioso central ……………………… ….49

10.8 Tuberculosis abdominal ……………………………………………………. 50

10.9 Pericarditis tuberculosa………………………………………………………. 50

10.10 Tuberculosis hematógena ………………………………………………… 51

  1. Diagnóstico de la infección tuberculosa ………………………………51

11.1 Tuberculina ………………………………………………………………………..51

11.2 Indicaciones de la prueba tuberculínica …………………………. ….52

11.3 Aplicación y lectura ……………………………………………………………. 53

11.4 Interpretación de la tuberculina……………………………………… ….54

  1. Tratamiento de la tuberculosis………………………………………….. 55

12.1 Fármacos antituberculosos ………………………………………………… 56

12.2 Esquemas de tratamiento recomendados ………………………….. 57

12.3 Retratamientos …………………………………………………………………. 65

12.4 Tuberculosis multirresistente …………………………………………… 68

12.5 Tratamiento de la infección tuberculosa latente ……………….. 69

  1. Vacuna BCG ……………………………………………………………………. 78
  2. Manejo en situaciones especiales …………………………………….. 80

14.1Tuberculosis y VIH ……………………………………………………………. 80

14.2 Tuberculosis infantil …………………………………………………………. 84

  1. Manejo en situaciones particulares ………………………………….. 87

15.1 Embarazo …………………………………………………………………………. 87

15.2 Enfermedad hepática ……………………………………………………….. 88

15.3 Insuficiencia renal ……………………………………………………………. 88

15.4 Silicotuberculosis …………………………………………………………….. 88

15.5 Tuberculosis y diabetes …………………………………………………… 88

15.6 Tuberculosis pulmonar negativa al cultivo………………………… 88

  1. Otras medidas no medicamentosas …………………………………. 89

16.1 Cirugía en Ttuberculosis …………………………………………………… 89

16.2 Esteroides en tuberculosis………………………………………………… 89

16.3 Hospitalización en tuberculosis …………………………………………. 90

  1. Actividades de vigilancia en salud pública………………………… 90
  2. Flujogramas …………………………………………………………………….. 91

Anexo ………………………………………………………………………………………. 94

Bibliografía (153 citas) ……………………………………………………………… 96

 

Tablas – Gráficos

Tabla 1. Grado de recomendación y nivel de evidencia ………………. 28

Tabla 2. Indicaciones de la American Thoracic Society ………………. 55

Tabla 3. Presentaciones recomendadas por la OMS, drogas de dosis fijas ……………… ……………………………………………………………………………65

Tabla 4. Esquema básico …………………………………………………………… 66

Tabla 5. Esquema……………………………………………………………………………………. 69

Tabla 6. Tratamiento ………………………………………………………………… 73

Tabla 7. Tratamiento acortado supervisado ……………………………… 77

Tabla 8. Esquema de retratamiento supervisado………………………. 77

Tabla 9. Tratamiento acortado supervisado para tuberculosis pulmonar y extrapulmonar en menores de 15 años ………………….. 77

 

FLUJOGRAMAS

  1. Detección y diagnóstico de casos pulmonares…………………… 91
  2. Diagnóstico de casos extrapulmonares ……………………………. 92
  3. Tratamiento …………………………………………………………………… 92
  4. Seguimiento ……………………………………………………………………. 93

 

PDF

http://www.nacer.udea.edu.co/pdf/libros/guiamps/guias11.pdf

February 7, 2015 at 12:44 pm

EBOLA – Recomendaciones para la atención de pacientes en áreas críticas (33 págs)

Medicina Intensiva OCT 2014 V.31 N.4 Supl.

Sociedad Argentina de Terapia Intensiva (SATI)

Agradecemos al Comité de Infectología Crítica de la Sociedad Argentina de Terapia Intensiva por compartir su trabajo poniéndolo a disposición de los colegas de todos los países de habla hispana. El artículo fue publicado en la revista “Medicina Intensiva”.

El propóstio de este documento es proporcionar un enfoque práctico a los intensivistas ante la enfermedad por virus del Ébola, con especial énfasis en el diagnóstico y el tratamiento oportunos, como así también en la prevención de su diseminación a otros pacientes o al personal sanitario.

El documento se redactó sobre la base de las recomendaciones de los organismos internacionales y del Ministerio de Salud de la Nación, adaptándolas a la realidad local.

Documento imprescindible fundado en la mejor evidencia científica y con aplicaciones prácticas elaborado por el Comité de Infectología Crítica de la SATI.

 

INDICE

  1. Objetivos
  2. Aspectos epidemiológicos y transmisión del virus del Ébola
  3. Sistema de notificación
  4. Toma y derivación de muestras para diagnósticos por laboratorio específicos y de rutina
  5. Infraestructura y manejo de pacientes en áreas críticas
  6. Medidas de prevención y control de infecciones
  7. Atención del paciente en áreas críticas
  8. Anexos
  9. Bibliografía

 

PDF

http://www.intramed.net/userfiles/2015/file/Ebola_SATI.pdf

 

January 22, 2015 at 4:06 pm

Older Posts


Calendar

March 2015
M T W T F S S
« Feb    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Posts by Month

Posts by Category


Follow

Get every new post delivered to your Inbox.

Join 82 other followers